In many types of tissue and culture cells, the interiors of adjacent cells communicate with each other through cell-to-cell channels. The fine structure of the cell-to-cell channel has been well studied and defined as a gap junction which consists of six identical, rod-shaped protein subunits [59]. This transmembrane channel permits free exchange of ions and small molecules between contacting cells [53]. This type of interaction between cells has been called "gap junctionalThis communication is readily proved by three different methods : electrophysiological, fluorescent dye transfer and metabolic cooperation methods [33].Cell communication has been thought to be regulated by the concentration of intracellular Ca2+ [45,46] and CAMP [17]. Calcium ion produces graded changes in cell communication [47]. cAMP modulates cell communication by stimulating the de novo synthesis of gap junctional protein [17].Since extensive reviews on the general properties of the gap junction and its physiological role have appeared in recent years [33,34], this short review will deal with a limited topic, namely, recent studies on the physiological role of gap junctional cell communication in the phenotypic manifestation of cancer.
I. CELL COMMUNICATION IN CANCER CELLSInvestigation of cell communication in cancer cells was first made in rat liver tumors including primary, Morris and Novikoff hepatomas by electrophysiological methods [35]. Subsequently, similar studies were performed in transplanted rat and hamster thyroid tumors [24] and human stomach carcinoma [28]. These earlier studies showed a lack or a decrease of cell communication between contacting cancer cells, indicating the predominance of communication-incompetent cells in malignant tumors. A solid tumor, which was developed by transplantation of MH 134 cells into the subcutaneous space of C3H/He mice showed a decreased level of communication as revealed by electrical coupling. The decrease of cell communication appeared to correlate with the characteristics of metastasis in the case of MH 134 cells [23]. In benign tumors, such as human follicular adenoma, human diffuse toxic goiter and nontoxic nodular goiter, con-